Biologics TIN Seminar: Oligonucleotides Therapies

This 2021 Biologics TIN event is the first of a series, to showcase innovative technologies developed at UCL for therapeutic applications involving oligonucleotides, antibodies, vaccines, peptides, exosomes and how to turn them in a biopharmaceutical product. The series of seminars will be followed by a Dragons’ den in July.

The session will be hosted by Professor Paul Dalby (Biologics TIN Chair), and includes an introduction to the Biologics Therapeutic Innovation Network (TIN) and the opportunities provided through the TIN, followed by two speakers from the Biologics community at UCL.

Speakers:

Prof Stephen Hart - Genetic therapies for respiratory diseases associated with cystic fibrosis. (25 mins)

Dr Haiyan Zhou - Novel therapeutic approaches using antisense oligonucleotides in neuromuscular disorder. (25 mins)

This event is open to all (UCL and non-UCL).